Cutaneous  ||| S:0 E:10 ||| JJ
immune  ||| S:10 E:17 ||| JJ
system  ||| S:17 E:24 ||| NN
Human  ||| S:24 E:30 ||| NNP
skin  ||| S:30 E:35 ||| NN
is  ||| S:35 E:38 ||| VBZ
constantly  ||| S:38 E:49 ||| RB
exposed  ||| S:49 E:57 ||| VBN
to  ||| S:57 E:60 ||| TO
environmental  ||| S:60 E:74 ||| JJ
factors ||| S:74 E:81 ||| NNS
.  ||| S:81 E:83 ||| .
It  ||| S:83 E:86 ||| PRP
does  ||| S:86 E:91 ||| VBZ
not  ||| S:91 E:95 ||| RB
only  ||| S:95 E:100 ||| JJ
function  ||| S:100 E:109 ||| NN
as  ||| S:109 E:112 ||| IN
a  ||| S:112 E:114 ||| DT
physical  ||| S:114 E:123 ||| JJ
barrier  ||| S:123 E:131 ||| NN
but  ||| S:131 E:135 ||| CC
also  ||| S:135 E:140 ||| RB
exhibits  ||| S:140 E:149 ||| VBZ
the  ||| S:149 E:153 ||| DT
capacity  ||| S:153 E:162 ||| NN
to  ||| S:162 E:165 ||| TO
generate  ||| S:165 E:174 ||| VB
innate  ||| S:174 E:181 ||| NNS
and  ||| S:181 E:185 ||| CC
adaptative  ||| S:185 E:196 ||| JJ
immune  ||| S:196 E:203 ||| JJ
responses ||| S:203 E:212 ||| NNS
.  ||| S:212 E:214 ||| .
So ||| S:214 E:216 ||| RB
,  ||| S:216 E:218 ||| ,
the  ||| S:218 E:222 ||| DT
skin  ||| S:222 E:227 ||| NN
protect  ||| S:227 E:235 ||| VB
the  ||| S:235 E:239 ||| DT
host  ||| S:239 E:244 ||| NN
from  ||| S:244 E:249 ||| IN
microbial  ||| S:249 E:259 ||| NN
and  ||| S:259 E:263 ||| CC
chemical  ||| S:263 E:272 ||| JJ
insults ||| S:272 E:279 ||| NN
.  ||| S:279 E:281 ||| .
However ||| S:281 E:288 ||| RB
,  ||| S:288 E:290 ||| ,
it  ||| S:290 E:293 ||| PRP
may  ||| S:293 E:297 ||| MD
also  ||| S:297 E:302 ||| RB
develop  ||| S:302 E:310 ||| VB
an  ||| S:310 E:313 ||| DT
immune  ||| S:313 E:320 ||| JJ
response  ||| S:320 E:329 ||| NN
against  ||| S:329 E:337 ||| IN
malignant  ||| S:337 E:347 ||| JJ
cells ||| S:347 E:352 ||| NNS
.  ||| S:352 E:354 ||| .
Cutaneous  ||| S:354 E:364 ||| JJ
immunity  ||| S:364 E:373 ||| NN
can  ||| S:373 E:377 ||| MD
be  ||| S:377 E:380 ||| VB
controlled  ||| S:380 E:391 ||| VBN
by  ||| S:391 E:394 ||| IN
some  ||| S:394 E:399 ||| DT
factors  ||| S:399 E:407 ||| NNS
such  ||| S:407 E:412 ||| JJ
as  ||| S:412 E:415 ||| IN
ageing ||| S:415 E:421 ||| NN
,  ||| S:421 E:423 ||| ,
ultraviolet  ||| S:423 E:435 ||| JJ
irradiation ||| S:435 E:446 ||| NN
,  ||| S:446 E:448 ||| ,
topical  ||| S:448 E:456 ||| JJ
therapies ||| S:456 E:465 ||| NNS
.  ||| S:465 E:467 ||| .
